Review: Central Nervous System Involvement in Mitochondrial Disease

Overview

Journal Neuropathol Appl Neurobiol

Specialty Neurology

Date 2016 Jun 12

PMID 27287935

Citations 30

Authors

N Z Lax

G S Gorman

D M Turnbull

Affiliations

Soon will be listed here.

Abstract

Mitochondrial respiratory chain defects are an important cause of inherited disorders affecting approximately 1 in 5000 people in the UK population. Collectively these disorders are termed 'mitochondrial diseases' and they result from either mitochondrial DNA mutations or defects in nuclear DNA. Although they are frequently multisystem disorders, neurological deficits are particularly common, wide-ranging and disabling for patients. This review details the manifold neurological impairments associated with mitochondrial disease, and describes the efforts to understand how they arise and progressively worsen in patients with mitochondrial disease. We describe advances in our understanding of disease pathogenesis through detailed neuropathological studies and how this has spurred the development of cellular and animal models of disease. We underscore the importance of continued clinical, molecular genetic, neuropathological and animal model studies to fully characterize mitochondrial diseases and understand mechanisms of neurodegeneration. These studies are instrumental for the next phase of mitochondrial research that has a particular emphasis on finding novel ways to treat mitochondrial disease to improve patient care and quality of life.

Citing Articles

Brain magnetic resonance imaging findings in Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): A case-based review.

Christodoulou M, Anagnostou N, Zikou A Radiol Case Rep. 2025; 20(3):1298-1305.

PMID: 39758336 PMC: 11700260. DOI: 10.1016/j.radcr.2024.11.047.

Mechanisms and pathologies of human mitochondrial DNA replication and deletion formation.

Bernardino Gomes T, Vincent A, Menger K, Stewart J, Nicholls T Biochem J. 2024; 481(11):683-715.

PMID: 38804971 PMC: 11346376. DOI: 10.1042/BCJ20230262.

Origins of tissue and cell-type specificity in mitochondrial DNA (mtDNA) disease.

Burr S, Chinnery P Hum Mol Genet. 2024; 33(R1):R3-R11.

PMID: 38779777 PMC: 11112380. DOI: 10.1093/hmg/ddae059.

Delineating mechanisms underlying parvalbumin neuron impairment in different neurological and neurodegenerative disorders: the emerging role of mitochondrial dysfunction.

Olkhova E, Smith L, Dennis B, Ng Y, LeBeau F, Gorman G Biochem Soc Trans. 2024; 52(2):553-565.

PMID: 38563502 PMC: 11088917. DOI: 10.1042/BST20230191.

Metabolic Determinants of Cerebellar Circuit Formation and Maintenance.

Gonzalez-Rodriguez M, Marin-Valencia I Cerebellum. 2023; 23(4):1626-1641.

PMID: 38123901 DOI: 10.1007/s12311-023-01641-2.

References

Attwell D, Laughlin S . An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab. 2001; 21(10):1133-45. DOI: 10.1097/00004647-200110000-00001. View

Hakonen A, Goffart S, Marjavaara S, Paetau A, Cooper H, Mattila K . Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet. 2008; 17(23):3822-35. DOI: 10.1093/hmg/ddn280. View

Mori O, Yamazaki M, Ohaki Y, Arai Y, Oguro T, Shimizu H . Mitochondrial encephalomyopathy with lactic acidosis and stroke like episodes (MELAS) with prominent degeneration of the intestinal wall and cactus-like cerebellar pathology. Acta Neuropathol. 2000; 100(6):712-7. DOI: 10.1007/s004010000209. View

Zhu Z, Yao J, Johns T, Fu K, De Bie I, MacMillan C . SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet. 1998; 20(4):337-43. DOI: 10.1038/3804. View

Mignarri A, Cenciarelli S, Da Pozzo P, Cardaioli E, Malandrini A, Federico A . Mitochondrial recessive ataxia syndrome: A neurological rarity not to be missed. J Neurol Sci. 2015; 349(1-2):254-5. DOI: 10.1016/j.jns.2014.12.040. View

Bender A, Krishnan K, Morris C, Taylor G, Reeve A, Perry R . High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 2006; 38(5):515-7. DOI: 10.1038/ng1769. View

Weissbein U, Benvenisty N, Ben-David U . Quality control: Genome maintenance in pluripotent stem cells. J Cell Biol. 2014; 204(2):153-63. PMC: 3897183. DOI: 10.1083/jcb.201310135. View

Hopkins S, Somoza A, Gilbert D . Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease. J Child Neurol. 2009; 25(6):752-6. DOI: 10.1177/0883073809343313. View

Pavlakis S, Phillips P, DiMauro S, De Vivo D, Rowland L . Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984; 16(4):481-8. DOI: 10.1002/ana.410160409. View

10.

Finsterer J, Barton P . Regression of stroke-like lesions in MELAS-syndrome after seizure control. Epileptic Disord. 2010; 12(4):330-4. DOI: 10.1684/epd.2010.0338. View

11.

Ohshita T, Oka M, Imon Y, Watanabe C, Katayama S, Yamaguchi S . Serial diffusion-weighted imaging in MELAS. Neuroradiology. 2000; 42(9):651-6. DOI: 10.1007/s002340000335. View

12.

Leigh D . Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry. 1951; 14(3):216-21. PMC: 499520. DOI: 10.1136/jnnp.14.3.216. View

13.

Emmanuele V, Garcia-Cazorla A, Huang H, Coku J, Dorado B, Cortes E . Decreased hippocampal expression of calbindin D28K and cognitive impairment in MELAS. J Neurol Sci. 2012; 317(1-2):29-34. PMC: 3345503. DOI: 10.1016/j.jns.2012.03.005. View

14.

Minobe S, Matsuda A, Mitsuhashi T, Ishikawa M, Nishimura Y, Shibata K . Vasodilatation of multiple cerebral arteries in early stage of stroke-like episode with MELAS. J Clin Neurosci. 2014; 22(2):407-8. DOI: 10.1016/j.jocn.2014.05.021. View

15.

Hasegawa H, Matsuoka T, Goto Y, Nonaka I . Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Ann Neurol. 1991; 29(6):601-5. DOI: 10.1002/ana.410290606. View

16.

Good C, Hoffman A, Hoffer B, Chefer V, Shippenberg T, Backman C . Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease. FASEB J. 2011; 25(4):1333-44. PMC: 3058704. DOI: 10.1096/fj.10-173625. View

17.

Tanji K, Gamez J, Cervera C, Mearin F, Ortega A, De La Torre J . The A8344G mutation in mitochondrial DNA associated with stroke-like episodes and gastrointestinal dysfunction. Acta Neuropathol. 2002; 105(1):69-75. DOI: 10.1007/s00401-002-0604-y. View

18.

Kaufmann P, Pascual J, Anziska Y, Gooch C, Engelstad K, Jhung S . Nerve conduction abnormalities in patients with MELAS and the A3243G mutation. Arch Neurol. 2006; 63(5):746-8. DOI: 10.1001/archneur.63.5.746. View

19.

Fan W, Waymire K, Narula N, Li P, Rocher C, Coskun P . A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science. 2008; 319(5865):958-62. PMC: 3049809. DOI: 10.1126/science.1147786. View

20.

Deschauer M, Tennant S, Rokicka A, He L, Kraya T, Turnbull D . MELAS associated with mutations in the POLG1 gene. Neurology. 2007; 68(20):1741-2. DOI: 10.1212/01.wnl.0000261929.92478.3e. View